These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25152383)

  • 21. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
    Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.
    Kochhäuser S; Alipour P; Haig-Carter T; Trought K; Hache P; Khaykin Y; Wulffhart Z; Pantano A; Tsang B; Birnie D; Verma A
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):273-279. PubMed ID: 27933666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermediate to long-term results of radiofrequency modified Maze procedure as an adjunct to open-heart surgery.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Ann Thorac Surg; 2008 Nov; 86(5):1409-14. PubMed ID: 19049723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
    Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonpharmacologic approaches to stroke prevention in atrial fibrillation.
    Whitlock RP; Hanif H; Danter M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S79-86. PubMed ID: 23790602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation.
    Tsadok MA; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Humphries KH; Tu JV; Behlouli H; Pilote L
    Circulation; 2012 Dec; 126(23):2680-7. PubMed ID: 23124034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation.
    Albåge A; Sartipy U; Kennebäck G; Johansson B; Scherstén H; Jidéus L;
    Ann Thorac Surg; 2017 Aug; 104(2):523-529. PubMed ID: 28242081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
    Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study.
    Yang WY; Du X; Jiang C; He L; Fawzy AM; Wang L; Liu C; Xia SJ; Chang SS; Guo XY; Li SN; Tang RB; Liu N; Bai R; Sang CH; Jiang CX; Yu RH; Long DY; Dong JZ; Lip GYH; Ma CS
    Europace; 2020 Jan; 22(1):90-99. PubMed ID: 31909431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maze procedure in patients with left ventricular dysfunction.
    Kim JB; Chong BK; Jung SH; Choo SJ; Chung CH; Lee JW
    Int J Cardiol; 2014 Jan; 170(3):331-7. PubMed ID: 24268862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
    Boriani G; Santini M; Lunati M; Gasparini M; Proclemer A; Landolina M; Padeletti L; Botto GL; Capucci A; Bianchi S; Biffi M; Ricci RP; Vimercati M; Grammatico A; Lip GY;
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):182-8. PubMed ID: 22373906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Kanaoka K; Nishida T; Iwanaga Y; Nakai M; Tonegawa-Kuji R; Nishioka Y; Myojin T; Okada K; Noda T; Kusano K; Miyamoto Y; Saito Y; Imamura T
    Eur Heart J; 2024 Feb; 45(7):522-534. PubMed ID: 38117227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler DO MJ; Day JD; Mallender C; Osborn JS; Weiss JP; Bunch TJ
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1241-1246. PubMed ID: 28845890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.).
    Ha AC; Singh N; Cox JL; Mancini GB; Dorian P; Fournier C; Gladstone DJ; Lockwood E; Shuaib A; Kajil M; Tsigoulis M; Gupta MK
    Can J Cardiol; 2016 Feb; 32(2):204-10. PubMed ID: 26195228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.